title: A potential vaccine for cocaine abuse prophylaxis.
abstract: Presently, there are estimated to be 1.5 to 2.0 million individuals infected with HIV-1 in the U.S. and about 12 million worldwide. In the U.S. over 90% of reported cases of AIDS occurred among two subgroups, homosexual males and intravenous substance abusers (IVSAs). Currently, there is no anti-cocaine addiction medication available. In order to explore vaccination as an alternative means for protection against cocaine addition, we immunized inbred male Fisher rats with either cocaine emulsification in complete Freund adjuvant (CFA) or with cocaine conjugated with keyhole limpet hemocyanin (KLH), as carrier plus CFA. Animals were initially immunized with 0.1 mg/animal of cocaine or cocaine-KLH. Animals were given a booster with the corresponding agents after 4 weeks. Ten animals/group were used. Controls received normal saline at the time of immunizations. These animals were injected, intraperitoneally, with 25 mg/kg of cocaine, and were examined for the analgesic effect of cocaine by the hot plate method. The average analgesic effect of cocaine was significantly reduced (p greater than 0.03) in animals immunized with cocaine-KLH (13.77 s) as compared to saline controls (21.6 s). Fifty percent of the animals (5/10) in the cocaine-KLH group and 33% of the animals (3/9) in the cocaine immunized group appeared completely resistant to the effect of cocaine on the central nervous system (CNS). We also have determined the levels of cocaine-specific antibodies produced by each animal by an ELISA method. Degree of protection from cocaine seems to correlate well with the amount of anti-cocaine antibodies produced by each animal (-0.61).(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Jefferson Medical College, Division of Infectious Diseases, Philadelphia, PA 19107.
authors.forename: O
authors.initials: O
authors.lastname: Bagasra
authors.forename: L J
authors.initials: LJ
authors.lastname: Forman
authors.forename: A
authors.initials: A
authors.lastname: Howeedy
authors.forename: P
authors.initials: P
authors.lastname: Whittle
mesh_terms: D000818:Animals; D000917:Antibody Formation; D000936:Antigen-Antibody Complex / Q000032:analysis; D003042:Cocaine / Q000276:immunology; D015932:Complement C3c / Q000032:analysis; D004797:Enzyme-Linked Immunosorbent Assay; D005620:Freund's Adjuvant; D006433:Hemocyanins; D007668:Kidney / Q000276:immunology; D008297:Male; D011897:Random Allocation; D051381:Rats; D011916:Rats, Inbred F344; D019966:Substance-Related Disorders / Q000517:prevention & control*; D014611:Vaccination; D014612:Vaccines
chemical_list: D000936:Antigen-Antibody Complex; D014612:Vaccines; D015932:Complement C3c; D005620:Freund's Adjuvant; D006433:Hemocyanins; C032808:keyhole-limpet hemocyanin; D003042:Cocaine